Meghmani Organics financials

·ChemicalsChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹543cr−11.5% on Q1 FY26
Net profit
₹48.2cr+280.0% on Q1 FY26
EBITDA margin
18.0%+7.1 pts on Q1 FY26
EPS
₹1.90+280.0% on Q1 FY26

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue543614−11.5%
EBITDA97.966.9+46.4%
EBITDA margin18.0%10.9%+7.1 pts
Profit before tax67.024.3+175.7%
Net profit48.212.7+280.0%
EPS₹1.90₹0.50+280.0%

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹543 crNet profit₹48.2 crNet margin8.9%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,400————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
16.816.822.733.161.1
726726829835820
2,109————
2,1032,1742,0801,5662,553
—+4.5%+32.8%−38.6%—
207176143−20.3341
9.9%8.1%6.9%−1.3%13.4%
88.457.534.6−112264
64.228.7−10.6−106238
3.1%1.3%−0.5%−6.8%9.3%
₹2.53₹1.13−₹0.42−₹4.17₹9.35
—+371.1%+90.0%−144.6%—
—22266.2250204
—−45.1−88.9−266−465
177177−22.7−16.5−261
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MOL₹55.04

Meghmani Organics Limited

· Chemicals
₹ CrorePeersIPLPUNJABCHEMINSECTICIDASTECBHARATRASDHARMAJGSPCROPADVANCEMcap ₹1,400 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,399.7
- Cash, Equiv & ST Investments61.133.122.716.816.8
+ Total Debt820.5834.9829.0726.0726.0
Enterprise Value————2,108.9
Revenue2,552.61,566.32,079.72,174.02,103.2
Growth %, YoY—-38.6+32.8+4.5—
EBITDA341.0-20.3142.7176.4207.5
Margin %13.36-1.296.868.129.86
EBIT264.0-112.534.657.588.4
Net Income237.7-106.0-10.628.764.2
Margin %9.31-6.77-0.511.323.05
EPS, Adj (current shares)9.35-4.17-0.421.132.53
Growth %, YoY—-144.6+90.0+371.1—
Cash from Operations204.5249.766.2221.7—
Capital Expenditures-465.1-266.2-88.9-45.1—
Free Cash Flow-260.7-16.5-22.7176.7176.7
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Meghmani Organics financials and key ratios

Prices at the previous close · figures from the company's filings with NSE

Meghmani Organics (NSE: MOL) had a market capitalisation of ₹1,400 crore at the previous close (₹55.04 a share), a PE ratio of 21.8 on the last four quarters' profit and a price-to-book ratio of 0.91. In FY26 its consolidated net profit was ₹28.7 crore on revenue of ₹2,174 crore; in Q1 FY27 (April–June 2026) it was ₹48.2 crore, up 280.0% year on year. Its debt-to-equity ratio was 0.47 on 31 March 2026. Promoters held 48.95% of the shares on 30 September 2026.

Share price used
₹55.04 · previous close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Meghmani Organics at a glance · consolidated

Market cap
₹1,400 Crat ₹55.04 · previous close
PE ratio (last 4 quarters)
21.848.7 on FY26 profit
Price to book (PB)
0.91book value ₹60.74 a share
ROE (FY26)
1.9%+2.6 pts vs FY25ROCE 3.1%
Debt to equity
0.47net debt ₹699 Cr
Promoter holding
48.95%unchanged vs 30 Jun 202630 September 2026
Net worth
₹1,545 Cr+1.9% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
₹177 Cr
EPS (FY26)
₹1.13

Questions

What is the Meghmani Organics PE ratio today?

Meghmani Organics' PE ratio is 21.8 at the previous close (₹55.04 a share): a market capitalisation of ₹1,400 crore divided by consolidated net profit of ₹64.2 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹28.7 crore) it is 48.7.

What is the Meghmani Organics debt to equity ratio?

Meghmani Organics' debt-to-equity ratio was 0.47 on 31 March 2026: borrowings of ₹726 crore against total equity of ₹1,545 crore. A year earlier, on 31 March 2025, it was 0.55.

What is the Meghmani Organics net worth?

Meghmani Organics' net worth — shareholders' equity in its consolidated balance sheet — was ₹1,545 crore on 31 March 2026, up 1.9% from ₹1,515 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,400 crore at the previous close.

What is the Meghmani Organics PB ratio (price to book value)?

Meghmani Organics' price-to-book (PB) ratio is 0.91 at the previous close: a market capitalisation of ₹1,400 crore divided by shareholders' equity (book value) of ₹1,545 crore on 31 March 2026. That is a book value of ₹60.74 per share against a share price of ₹55.04.

What is the Meghmani Organics ROE and ROCE?

In FY26, Meghmani Organics' return on equity (ROE) was 1.9% and its return on capital employed (ROCE) was 3.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −0.7% and ROCE 1.8%.

What is the Meghmani Organics book value per share?

Meghmani Organics' book value per share was ₹60.74 on 31 March 2026: shareholders' equity of ₹1,545 crore divided by the 25.43 crore shares in issue, up 1.9% from ₹59.58 a year earlier. The share price at the previous close was ₹55.04.

What is the Meghmani Organics market cap?

Meghmani Organics' market capitalisation was ₹1,400 crore at the previous close: 25.43 crore shares at ₹55.04 each.

Is Meghmani Organics debt free?

No. Meghmani Organics had borrowings of ₹726 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.47. Its cash and current investments were ₹26.5 crore, so its net debt was ₹699 crore.

What is the Meghmani Organics EPS?

Meghmani Organics' basic earnings per share (EPS) were ₹1.13 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹2.53.

What is the Meghmani Organics promoter holding?

Promoters held 48.95% of Meghmani Organics on 30 September 2026, unchanged from the previous quarter and down 0.03 percentage points from 48.98% a year earlier, according to the shareholding pattern filed with NSE.

What is the Meghmani Organics free cash flow?

In FY26, Meghmani Organics generated ₹222 crore of cash from operations and spent ₹45.1 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹177 crore. In FY25 it was −₹22.7 crore.

What are the Meghmani Organics latest quarterly results?

Meghmani Organics' latest results are for Q1 FY27 (April–June 2026), filed on 29 July 2026: consolidated net profit ₹48.2 crore, up 280.0% from ₹12.7 crore in Q1 FY26; revenue from operations ₹543 crore, down 11.5% year on year.

What is the Meghmani Organics shareholding pattern?

On 30 September 2026, Meghmani Organics' shares were held by promoters 48.95%, foreign portfolio investors (FII/FPI) 0.84%, domestic institutions (DII) 0.00% and retail and other non-institutional investors 50.17%. Over the year, FII holding was down 0.64 percentage points from 1.48% and DII holding was unchanged.

What is the Meghmani Organics revenue and profit in FY26?

In FY26 (April 2025–March 2026), Meghmani Organics' consolidated net profit was ₹28.7 crore, against a loss of ₹10.6 crore in FY25, on revenue from operations of ₹2,174 crore (up 4.5%). Over three years, from FY23, net profit was down 87.9%.

Meghmani Organics vs India Pesticides: how do they compare?

In FY26, Meghmani Organics earned net profit of ₹28.7 crore on revenue of ₹2,174 crore, against ₹120 crore on ₹1,057 crore for India Pesticides. Meghmani Organics' operating margin was 2.6% (India Pesticides 14.4%) and its return on equity 1.9% (India Pesticides 12.6%).

When are the Meghmani Organics next results?

Meghmani Organics will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.

How does Meghmani Organics compare with its peers?

On FY26 consolidated figures, against India Pesticides, Punjab Chemicals & Crop Protection and Insecticides: Meghmani Organics' operating margin of 2.6% is the lowest of the four (India Pesticides 14.4%, Punjab Chemicals & Crop Protection 8.7%, Insecticides 9.0%; peer average 10.7%); its return on equity of 1.9% is the lowest of the four (India Pesticides 12.6%, Punjab Chemicals & Crop Protection 16.2%, Insecticides 12.1%; peer average 13.6%); its revenue growth over three years of −5.2% a year is the lowest of the four (India Pesticides 6.1% a year, Punjab Chemicals & Crop Protection 0.8% a year, Insecticides 5.9% a year; peer average 4.3% a year).

Where do these Meghmani Organics figures come from?

From Meghmani Organics' own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.